FDA sends Philips warning letter for CT, nuclear imaging systems
The FDA issued a warning to Philips Medical Systems about problems with manufacturing procedures for its CT and nuclear imaging systems. The problems include failures to oversee proper device design and proper procedures to handle complaints. Inspections conducted at Philips' Cleveland facility, from July 24, 2007, through Sept. 27, 2007, and from Oct. 22, 2007, through Nov. 9, 2007, revealed that the devices were adulterated, said FDA officials. The agency noted that failure to promptly correct the violations may result in regulatory action being initiated by the FDA "without further notice," including seizure, injunction and/or civil money penalties.
- Will More Pioneer ACOs Defect?
- Interventional Radiology No Longer a Sub-Specialty
- Charity HealthCare Conundrum Brewing Among Providers
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- mHealth Tackles Readmissions
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013